Healio

Tolebrutinib delays onset of MS disability progression in phase 3 trial

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. An oral brain-penetrant therapeutic delayed the onset of ...
Psychology Today

Disability and Strengths: We Need Phase 3!

We cannot escape disability. If you live long enough, you will experience some kind of disability. It might be a “hidden” disability such as depression, alcohol addiction, or an eating disorder. It ...
Seeking Alpha

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis Tolebrutinib has the potential to be the ...
Seeking Alpha

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial

– Reduced Relative Risk of 24-Week Confirmed Disability Worsening Events by 20% in Overall Study Population Compared to Placebo; Even More Prominent 30% Reduction in High Unmet Need Population of ...